152 related articles for article (PubMed ID: 34022674)
21. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.
Smalberg JH; Arends LR; Valla DC; Kiladjian JJ; Janssen HL; Leebeek FW
Blood; 2012 Dec; 120(25):4921-8. PubMed ID: 23043069
[TBL] [Abstract][Full Text] [Related]
22. [Extensive portocava thrombosis revealing a primary antiphospholipid syndrome: a case report].
Belkahla N; Maamouri N; Ouerghi H; Cheikh I; Hamida SB; Bouzid H; Ammar AB
Rev Med Interne; 2008 Jun; 29(6):504-7. PubMed ID: 18407381
[TBL] [Abstract][Full Text] [Related]
23. [Complexities and challenges in the management of portal vein thrombosis in cirrhosis].
Chu HK; Chen LY; Yang L
Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):196-198. PubMed ID: 33902183
[TBL] [Abstract][Full Text] [Related]
24. Unsuspected primary hepatic angiosarcoma associated with portal vein thrombosis complicating cirrhosis.
Pimentel Cauduro SK; Petrovic LM; Sodeman TC; Ishitani MB; Menon KV; Hay JE
Liver Transpl; 2002 Nov; 8(11):1080-1. PubMed ID: 12424726
[No Abstract] [Full Text] [Related]
25. Editorial: acute non-cirrhotic and non-malignant portal vein thrombosis-who should be candidates for interventional treatment?
Zhang D; Xu S; Tian Y; Qi X
Aliment Pharmacol Ther; 2020 Aug; 52(4):725-728. PubMed ID: 32886391
[No Abstract] [Full Text] [Related]
26. Budd-Chiari Syndrome in a patient with Multiple Hypercoagulopathies.
Kraleti S
J Ark Med Soc; 2015 Oct; 112(6):90-1. PubMed ID: 26552285
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.
Intagliata NM; Caldwell SH; Tripodi A
Gastroenterology; 2019 May; 156(6):1582-1599.e1. PubMed ID: 30771355
[TBL] [Abstract][Full Text] [Related]
28. Nonmalignant partial portal vein thrombosis in liver cirrhosis: to treat or not to treat?
Qi X; Wang J; Chen H; Han G; Fan D
Radiology; 2013 Mar; 266(3):994-5. PubMed ID: 23431230
[No Abstract] [Full Text] [Related]
29. Editorial: acute non-cirrhotic and non-malignant portal vein thrombosis--who should be candidates for interventional treatment? Authors' reply.
Rössle M; Bettinger D; Thimme R; Schultheiss M
Aliment Pharmacol Ther; 2020 Aug; 52(4):729-730. PubMed ID: 32886377
[No Abstract] [Full Text] [Related]
30. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management.
Brière JB
Semin Thromb Hemost; 2006 Apr; 32(3):208-18. PubMed ID: 16673275
[TBL] [Abstract][Full Text] [Related]
31. Liver in haematological disorders.
Pieri G; Theocharidou E; Burroughs AK
Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):513-30. PubMed ID: 24090939
[TBL] [Abstract][Full Text] [Related]
32. JAK2 mutation: The best diagnostic tool for myeloproliferative disease in splanchnic vein thrombosis?
Janssen HL; Leebeek FW
Hepatology; 2006 Dec; 44(6):1391-3. PubMed ID: 17133464
[No Abstract] [Full Text] [Related]
33. Transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal vein thrombosis.
Modaresi Esfeh J; Ansari-Gilani K
Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):762-763. PubMed ID: 32355095
[No Abstract] [Full Text] [Related]
34. [Budd-Chiari syndrome in polycystic kidney disease].
Schwaller KH; Pirovino M
Praxis (Bern 1994); 2001 Apr; 90(17):738-40. PubMed ID: 11387814
[TBL] [Abstract][Full Text] [Related]
35. Vascular disorders of the liver.
Valla DC
Acta Gastroenterol Belg; 2003; 66(4):294-7. PubMed ID: 14989053
[No Abstract] [Full Text] [Related]
36. EUS-guided FNA of a portal vein thrombus in hepatocellular carcinoma.
Kayar Y; Turkdogan KA; Baysal B; Unver N; Danalioglu A; Senturk H
Pan Afr Med J; 2015; 21():86. PubMed ID: 26491529
[TBL] [Abstract][Full Text] [Related]
37. [Widespread mesenteric venous thrombosis and cirrhosis diagnosed with autopsy].
Kömür İ; Özdemirel RÖ; Başpınar B; Şam B; Anık Karayel F
Ulus Travma Acil Cerrahi Derg; 2015 Sep; 21(5):414-7. PubMed ID: 26388282
[TBL] [Abstract][Full Text] [Related]
38. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
Chung JW; Kim GH; Lee JH; Ok KS; Jang ES; Jeong SH; Kim JW
Clin Mol Hepatol; 2014 Dec; 20(4):384-91. PubMed ID: 25548745
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.
Karaköse S; Oruç N; Zengin M; Akarca US; Ersöz G
Turk J Gastroenterol; 2015 Jan; 26(1):42-8. PubMed ID: 25698270
[TBL] [Abstract][Full Text] [Related]
40. Vascular disorders of the liver.
DeLeve LD; Valla DC; Garcia-Tsao G;
Hepatology; 2009 May; 49(5):1729-64. PubMed ID: 19399912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
